logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

ASCO 2018—Denosumab + aromatase inhibitor reduces cancer development/recurrence and death in postmenopausal patients with breast cancer

First results on postmenopausal women from the ABCSG-18 trial.